Advanced search
Publication Cover
Modern Rheumatology Volume 24, 2014 - Issue 3
Journal homepage
523
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, JapanCorrespondence[email protected]
,
Tsutomu TakeuchiDivision of Rheumatology, School of Medicine, Keio University, Tokyo
,
Koichi AmanoDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
,
Kentaro HanamiThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
,
Masao NawataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
,
Shunsuke FukuyoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
,
Hideto KamedaDivision of Rheumatology, School of Medicine, Keio University, Tokyo
,
Yuko KanekoDivision of Rheumatology, School of Medicine, Keio University, Tokyo
,
Takahiko KurasawaDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama
,
Hayato NagasawaDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama
,
Daisuke HoshiInstitute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
,
Eri SatoInstitute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
&
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
 show all
Pages 399-404 | Received 19 Mar 2013, Accepted 15 May 2013, Published online: 05 Nov 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Francesca Bartoli, Sangmee Bae, Laura Cometi, Marco Matucci Cerinic & Daniel E Furst. (2018) Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018. Expert Review of Clinical Immunology 14:7, pages 539-547.
Read now
Hiroaki Matsuno & Kou Katayama. (2017) Effectiveness of golimumab for rheumatoid arthritis in patients with an inadequate response to tocilizumab. Modern Rheumatology 27:2, pages 246-251.
Read now
T Iwata, H Ito, M Furu, M Hashimoto, T Fujii, M Ishikawa, M Azukizawa, Y Hamamoto, T Mimori, H Akiyama & S Matsuda. (2016) Systemic effects of surgical intervention on disease activity, daily function, and medication in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 45:5, pages 356-362.
Read now
Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Kanzo Amano, Ryuji Nagamine, Won Park, Kazuko Shiozawa, Michishi Tsukano, James Cheng-Chung Wei, Jing Shao, Osamu Togo & Hideki Mashimo. (2016) Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial. Modern Rheumatology 26:1, pages 15-23.
Read now

Articles from other publishers (10)

Takeshi Mochizuki, Naoko Koenuma, Koichiro Yano, Katsunori Ikari, Ryo Hiroshima & Ken Okazaki. (2023) Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission. Modern Rheumatology.
Crossref
Hind Hashwah, Katrin Bertram, Kristin Stirm, Anna Stelling, Cheuk‐Ting Wu, Sabrina Kasser, Markus G Manz, Alexandre P Theocharides, Alexandar Tzankov & Anne Müller. (2019) The IL ‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma . EMBO Molecular Medicine 11:10.
Crossref
Juliana Maia Teixeira, Carlos Amílcar Parada & Cláudia Herrera Tambeli. (2017) A cyclic pathway of P2 × 7, bradykinin, and dopamine receptor activation induces a sustained articular hyperalgesia in the knee joint of rats. Inflammation Research 67:4, pages 301-314.
Crossref
Juliana Maia Teixeira, Franciane Bobinski, Carlos Amílcar Parada, Kathleen A. Sluka & Cláudia Herrera Tambeli. (2016) P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis. Molecular Neurobiology 54:8, pages 6174-6186.
Crossref
Irene Notario Ferreira, Miguel Angel Ferrer González, Pilar Morales Garrido, Alfonso González Utrilla, Antonio García Sanchez, María José Soto Pino, Evelyn Suero Rosario, Cristina Caro Hernández, Isabel Añón Oñate, Lorena Pérez Albaladejo & Rafael Cáliz Cáliz. (2017) Two-year Efficacy of tocilizumab in Patients With Active Rheumatoid Arthritis in Clinical Practice. Reumatología Clínica (English Edition) 13:2, pages 78-84.
Crossref
Irene Notario Ferreira, Miguel Angel Ferrer González, Pilar Morales Garrido, Alfonso González Utrilla, Antonio García Sanchez, María José Soto Pino, Evelyn Suero Rosario, Cristina Caro Hernández, Isabel Añón Oñate, Lorena Pérez Albaladejo & Rafael Cáliz Cáliz. (2017) Eficacia a 2 años de tocilizumab en pacientes con artritis reumatoide activa en la práctica clínica habitual. Reumatología Clínica 13:2, pages 78-84.
Crossref
Daniel Aletaha, Clifton O BinghamIIIIII, Yoshiya Tanaka, Prasheen Agarwal, Regina Kurrasch, Paul P Tak & Sharon Popik. (2017) Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study. The Lancet 389:10075, pages 1206-1217.
Crossref
A. Rubbert-Roth. (2015) Wechsel innerhalb der Wirkstoffgruppe oder Wechsel des WirkprinzipsSwitching within the active ingredient group or changing the mechanism of action. rheuma plus 14:4, pages 100-108.
Crossref
A. Rubbert-Roth. (2015) Wechsel innerhalb der Wirkstoffgruppe oder Wechsel des WirkprinzipsSwitching within the active ingredient group or changing the mechanism of action. Zeitschrift für Rheumatologie 74:5, pages 406-413.
Crossref
Dulshara Sachini Amarasekara, Jiyeon Yu & Jaerang Rho. (2015) Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases. Journal of Immunology Research 2015, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.